247
Views
0
CrossRef citations to date
0
Altmetric
CASE SERIES

Hyaluronic Acid Fillers and ASIA Syndrome: Case Studies

ORCID Icon & ORCID Icon
Pages 2763-2771 | Received 03 Jul 2023, Accepted 29 Aug 2023, Published online: 05 Oct 2023

References

  • Shoenfeld Y, Agmon-Levin N. ‘ASIA’ - autoimmune/inflammatory syndrome induced by adjuvants. J Autoimmun. 2011;36(1):4–8. doi:10.1016/j.jaut.2010.07.003
  • Watad A, Bragazzi NL, McGonagle D, et al. Autoimmune/inflammatory syndrome induced by adjuvants (ASIA) demonstrates distinct autoimmune and autoinflammatory disease associations according to the adjuvant subtype: insights from an analysis of 500 cases. Clin Immunol. 2019;203:1–8. doi:10.1016/j.clim.2019.03.007
  • Alijotas-Reig J, Esteve-Valverde E, Gil-Aliberas N, et al. Autoimmune/inflammatory syndrome induced by adjuvants-ASIA-related to biomaterials: analysis of 45 cases and comprehensive review of the literature. Immunol Res. 2018;66(1):120–140. doi:10.1007/s12026-017-8980-5
  • Montealegre G, Uribe R, Martínez-Ceballos MA, et al. ASIA syndrome symptoms induced by gluteal biopolymer injections: case-series and narrative review. Toxicol Rep. 2021;8:303–314. doi:10.1016/j.toxrep.2021.01.011
  • Cohen Tervaert JW. Autoinflammatory/autoimmunity syndrome induced by adjuvants (ASIA; Shoenfeld’s syndrome): a new flame. Autoimmun Rev. 2018;17(12):1259–1264. doi:10.1016/j.autrev.2018.07.003
  • Decates T, Kadouch J, Velthuis P, et al. Immediate nor delayed type hypersensitivity plays a role in late inflammatory reactions after hyaluronic acid filler injections. Clin Cosmet Investig Dermatol. 2021;14:581–589. doi:10.2147/CCID.S312198
  • Jara LJ, Garcia-Collinot G, Medina G, et al. Severe manifestations of autoimmune syndrome induced by adjuvants (Shoenfeld’s syndrome). Immunol Res. 2017;65(1):8–16. doi:10.1007/s12026-016-8811-0
  • Facciolà A, Visalli G, Laganà A, et al. An overview of vaccine adjuvants: current evidence and future perspectives. Vaccines. 2022;10(5):819. doi:10.3390/vaccines10050819
  • ASDS report. Available from: https://www.asds.net/skin-experts/news-room/press-releases/asds-members-performed-nearly-14-million-treatments-in-2019. Accessed September 3, 2023.
  • Bukhari SNA, Roswandi NL, Waqas M, et al. Hyaluronic acid, a promising skin rejuvenating biomedicine: a review of recent updates and pre-clinical and clinical investigations on cosmetic and nutricosmetic effects. Int J Biol Macromol. 2018;120(Pt B):1682–1695. doi:10.1016/j.ijbiomac.2018.09.188
  • Rohrich RJ, Bartlett EL, Dayan E. Practical approach and safety of hyaluronic acid fillers. Plast Reconstr Surg Glob Open. 2019;7(6):e2172. doi:10.1097/GOX.000000000000217
  • Viscusi KS, Hanke CW. Soft tissue augmentation. In: Baran R, Maybach HI, editors. Textbook of Cosmetic Dermatology, 5th ed. CRC Press; 2017:473–480.
  • Wang F, Garza LA, Kang S, et al. In vivo stimulation of de novo collagen production caused by cross-linked hyaluronic acid dermal filler injections in photodamaged human skin. Arch Dermatol. 2007;143(2):155–163. doi:10.1001/archderm.143.2.155
  • Chung KL, Convery C, Ejikeme I, et al. A systematic review of the literature of delayed inflammatory reactions after hyaluronic acid filler injection to estimate the incidence of delayed type hypersensitivity reaction. Aesthet Surg J. 2020;40(5):NP286–NP300. doi:10.1093/asj/sjz222
  • Heydenrych I, De Boulle K, Kapoor KM, et al. The 10-Point Plan 2021: updated Concepts for Improved Procedural Safety During Facial Filler Treatments. Clin Cosmet Investig Dermatol. 2021;14:779–814. doi:10.2147/CCID.S315711
  • Bitterman-Deutsch O, Kogan L, Nasser F. Delayed immune mediated adverse effects to hyaluronic acid fillers: report of five cases and review of the literature. Dermatol Reports. 2015;7(1):5851. doi:10.4081/dr.2015.5851
  • Decates TS, Velthuis PJ, Jhingoerie R, et al. No association found between late-onset inflammatory adverse events after soft tissue filler injections and the adaptive immune system. J Cosmet Dermatol. 2023;22(2):458–463. doi:10.1111/jocd.15098
  • Owczarczyk-Saczonek A, Zdanowska N, Wygonowska E, et al. The immunogenicity of hyaluronic fillers and its consequences. Clin Cosmet Investig Dermatol. 2021;14:921–934. doi:10.2147/CCID.S316352
  • Sadeghpour M, Quatrano NA, Bonati LM, et al. Delayed-Onset Nodules to differentially crosslinked hyaluronic acids: comparative incidence and risk assessment. Dermatol Surg. 2019;45(8):1085–1094. doi:10.1097/DSS.0000000000001814
  • Hee CK, Messina DJ. In vitro inflammatory and immune response to uncrosslinked hyaluronic acid (HA) and HA fillers. J Immunol Regen Med. 2022;17. doi:10.1016/j.regen.2022.100065
  • Flux MC, Lowry CA. Inflammation as a mediator of stress-related psychiatric disorders. In: Zigmond MJ, Wiley CA, Chesselet MF, editors. Neurobiology of Brain Disorders. 2nd ed. Academic Press; 2023:885–911.
  • Shalmon D, Cohen JL, Landau M, et al. Management Patterns of Delayed Inflammatory Reactions to Hyaluronic Acid Dermal Fillers: an Online Survey in Israel. Clin Cosmet Investig Dermatol. 2020;13:345‐349. doi:10.2147/CCID.S247315
  • Kaczor T. Recognizing Autoimmune/Autoinflammatory Syndrome Induced by Adjuvants (ASIA). Useful knowledge for identifying patients with underlying immune dysregulation. Nat Med J. 2017;9:676.
  • Aggarwal R, Namjou B, Li S, et al. Male-only systemic lupus. J Rheumatol. 2010;37(7):1480–1487. doi:10.3899/jrheum.090726